scholarly journals Severe combined immunodeficiency mouse-psoriatic human skin xenograft model: A modern tool connecting bench to bedside

2014 ◽  
Vol 80 (3) ◽  
pp. 204 ◽  
Author(s):  
Smriti Kundu-Raychaudhuri ◽  
John Peters ◽  
SibaP Raychaudhuri ◽  
Ananya Datta-Mitra ◽  
ChristineJ Abria
2019 ◽  
Vol 843 ◽  
pp. 190-198
Author(s):  
Haruna Sasaki-Iwaoka ◽  
Katsunari Taguchi ◽  
Yohei Okada ◽  
Emiko Imamura ◽  
Satoshi Kubo ◽  
...  

2000 ◽  
Vol 77 (1) ◽  
pp. 137-148 ◽  
Author(s):  
Krishnansu Sujata Tewari ◽  
Jason A. Taylor ◽  
Shu Y. Liao ◽  
Philip J. DiSaia ◽  
Robert A. Burger ◽  
...  

Angiogenesis ◽  
2006 ◽  
Vol 9 (4) ◽  
pp. 171-176 ◽  
Author(s):  
Marian T. Nakada ◽  
Gaoyuan Cao ◽  
Patricia M. Sassoli ◽  
Horace M. DeLisser

2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Aiping Liu ◽  
Yin Long ◽  
Jun Li ◽  
Long Gu ◽  
Aos Karim ◽  
...  

Abstract Background Electrostimulation (ES) therapy for wound healing is limited in clinical use due to barriers such as cumbersome equipment and intermittent delivery of therapy. Methods We adapted a human skin xenograft model that can be used to directly examine the nanogenerator-driven ES (NG-ES) effects on human skin in vivo—an essential translational step toward clinical application of the NG-ES technique for wound healing. Results We show that NG-ES leads to rapid wound closure with complete restoration of normal skin architecture within 7 days compared to more than 30 days in the literature. NG-ES accelerates the inflammatory phase of wound healing with more rapid resolution of neutrophils and macrophages and enhances wound bed perfusion with more robust neovascularization. Conclusion Our results support the translational evaluation and optimization of the NG-ES technology to deliver convenient, efficient wound healing therapy for use in human wounds. Graphic abstract


2019 ◽  
Vol 4 (37) ◽  
pp. eaav8995 ◽  
Author(s):  
Maria M. Klicznik ◽  
Peter A. Morawski ◽  
Barbara Höllbacher ◽  
Suraj R. Varkhande ◽  
Samantha J. Motley ◽  
...  

Tissue-resident memory T cells (TRM) persist locally in nonlymphoid tissues where they provide frontline defense against recurring insults. TRM at barrier surfaces express the markers CD103 and/or CD69, which function to retain them in epithelial tissues. In humans, neither the long-term migratory behavior of TRM nor their ability to reenter the circulation and potentially migrate to distant tissue sites has been investigated. Using tissue explant cultures, we found that CD4+CD69+CD103+ TRM in human skin can down-regulate CD69 and exit the tissue. In addition, we identified a skin-tropic CD4+CD69−CD103+ population in human lymph and blood that is transcriptionally, functionally, and clonally related to the CD4+CD69+CD103+ TRM population in the skin. Using a skin xenograft model, we confirmed that a fraction of the human cutaneous CD4+CD103+ TRM population can reenter circulation and migrate to secondary human skin sites where they reassume a TRM phenotype. Thus, our data challenge current concepts regarding the strict tissue compartmentalization of CD4+ T cell memory in humans.


2018 ◽  
Author(s):  
M. M. Klicznik ◽  
P. A. Morawski ◽  
B. Höllbacher ◽  
S. R. Varkhande ◽  
S. Motley ◽  
...  

AbstractTissue-resident memory T cells (TRM) persist locally in non-lymphoid tissues where they provide front-line defense against recurring insults. TRM at barrier surfaces express the markers CD103 and/or CD69 which function to retain them in epithelial tissues. In humans, neither the long-term migratory behavior of TRM nor their ability to re-enter the circulation and potentially migrate to distant tissue sites have been investigated. Using tissue explant cultures, we found that CD4+CD69+CD103+ TRM in human skin can downregulate CD69 and exit the tissue.Additionally, we identified a skin-tropic CD4+CD69−CD103+ population in human lymph and blood that is transcriptionally, functionally and clonally related to the CD4+CD69+CD103+ TRM population in the skin. Using a skin xenograft model, we confirmed that a fraction of the human cutaneous CD4+CD103+ TRM population can re-enter circulation, and migrate to secondary human skin sites where they re-assume a TRM phenotype. Thus, our data challenge current concepts regarding the strict tissue compartmentalization of CD4+ T cell memory in humans.One Sentence SummaryHuman CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects, and these cells can seed distant skin sites.


Sign in / Sign up

Export Citation Format

Share Document